A UK study has shown that routine childhood screening for type 1 diabetes (T1D) is feasible and could prevent thousands of children being diagnosed during a medical emergency. The first phase of the ...

Disney's sequel is also doing astounding business overseas — where it has escaped the China curse to become the second-top-grossing Western pic ever behind 'Avengers: Endgame.' By Pamela McClintock ...

A potential cure for type 1 diabetes has been identified by scientists in a new mouse study. In an animal study, researchers at Stanford School of Medicine discovered that resetting the immune system ...

Danish researchers were examining the use of medications during and after pregnancy when they noticed a clear trend: The number of women using weight-loss drugs like Ozempic and Wegovy soon after ...

GLP-1 drugs tirzepatide and semaglutide may offer increased protection against heart attack, stroke and death from any cause, according to a November study published in Nature Medicine and presented ...

Dr. Céline Gounder, an internist, epidemiologist and infectious disease specialist, is a CBS News medical contributor as well as senior fellow and editor-at-large for public health at KFF Health News.

What’s one thing every leader can do to make sure employees are happy at work and engaged with their jobs? Make sure they can trust in you, your organization, and one another. That’s the finding in a ...

VIENNA — Just over half the adults without diabetes who started taking the GLP-1 semaglutide (Wegovy) for weight loss discontinued treatment within a year, with a marked drop-off in younger adults, ...

People who consumed the highest levels of certain artificial sweeteners — equivalent to just one diet soda a day — saw a significant decline in their ability to remember and recall words when compared ...

Share on Pinterest A new study observed that people taking GLP-1 drugs had improved asthma symptoms. Felix Hörhager/picture alliance via Getty Images Researchers based in the United Kingdom recently ...

Isabella Cueto covers the leading causes of death and disability: chronic diseases. Her focus includes autoimmune conditions and diseases of the lungs, kidneys, liver (and more). She writes about ...

After three years, only about 1 in 12 individuals taking GLP-1s to treat obesity remained on the therapy, according to a Prime Therapeutics study published on June 25. Prime is owned by 19 Blue Cross ...